Controlled release systems for DNA delivery

Molecular Therapy

Volumn 10, Issue 1, 2004, Pages 19-26

  Pannier, Angela K ^a   Shea, Lonnie D ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Northwestern University   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Biomaterials; Gene therapy; Plasmid; Substrate mediated delivery; Tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; COLLAGEN; ETHYLENE VINYL ACETATE COPOLYMER; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; HYALURONIC ACID; INTERLEUKIN 12; INTERLEUKIN 2; INTERSTITIAL COLLAGENASE; LACTATE DEHYDROGENASE; MACROGOL; PARATHYROID HORMONE[1-34]; PLASMID DNA; PLASMID VECTOR; PLATELET DERIVED GROWTH FACTOR; POLYANHYDRIDE; POLYETHYLENEIMINE; POLYGLACTIN; POLYLYSINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VIRUS ANTIGEN; VIRUS VECTOR;

BINDING AFFINITY; BINDING SITE; CONTROLLED DRUG RELEASE; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; POLYMERS;

EID: 3042814407     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.03.020     Document Type: Review

References (101)

1. Luo D. Saltzman W.M. Enhancement of transfection by physical concentration of DNA at the cell surface Nat. Biotechnol. 18 2000 893-895
2. Palsson B. Andreadis S. The physico-chemical factors that govern retrovirus-mediated gene transfer Exp. Hematol. 25 1997 94-102
3. Tam P. et al. Stabilized plasmid-lipid particles for systemic gene therapy Gene Ther. 7 2000 1867-1874
4. Layne S.P. et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus Virology 189 1992 695-714
5. Ochiya T. Nagahara S. Sano A. Itoh H. Terada M. Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines Curr. Gene Ther. 1 2001 31-52
6. Scherer F. Schillinger U. Putz U. Stemberger A. Plank C. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo J. Gene Med. 4 2002 634-643
7. Shea L.D. Smiley E. Bonadio J. Mooney D.J. DNA delivery from polymer matrices for tissue engineering Nat. Biotechnol. 17 1999 551-554
8. Sakiyama-Elbert S.E. Panitch A. Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery FASEB J. 15 2001 1300-1302
9. Proctor R.A. Fibronectin: a brief overview of its structure, function, and physiology Rev. Infect. Dis. 9 Suppl. 4 1987 S317-S321
10. Bajaj B. Lei P. Andreadis S.T. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization Biotechnol. Prog. 17 2001 587-596
11. Levy R.J. et al. Localized adenovirus gene delivery using antiviral IgG complexation Gene Ther. 8 2001 659-667
12. Segura T. Shea L.D. Surface-tethered DNA complexes for enhanced gene delivery Bioconjugate Chem. 13 2002 621-629
13. Putney S.D. Burke P.A. Improving protein therapeutics with sustained-release formulations Nat. Biotechnol. 16 1998 153-157
14. Norde W. Lyklema J. Why proteins prefer interfaces J. Biomater. Sci. Polym. Ed. 2 1991 183-202
15. Panyam J. Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Delivery Rev. 55 2003 329-347
16. Mathiowitz E. et al. Biologically erodable microspheres as potential oral drug delivery systems Nature 386 1997 410-414
17. Ochiya T. et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet Nat. Med. 5 1999 707-710
18. Bonadio J. Smiley E. Patil P. Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration Nat. Med. 5 1999 753-759
19. Xie Y. Yang S.T. Kniss D.A. Three-dimensional cell-scaffold constructs promote efficient gene transfection: implications for cell-based gene therapy Tissue Eng. 7 2001 585-598
20. Varde N.K. Pack D.W. Microspheres for controlled release drug delivery Expert Opin. Biol. Ther. 4 2004 35-51
21. Batycky R.P. Hanes J. Langer R. Edwards D.A. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres J. Pharm. Sci. 86 1997 1464-1477
22. Ando S. Putnam D. Pack D.W. Langer R. PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization J. Pharm. Sci. 88 1999 126-130
23. Jang J.H. Shea L.D. Controllable delivery of non-viral DNA from porous scaffolds J. Controlled Release 86 2003 157-168
24. Samuel R.E. et al. Delivery of plasmid DNA to articular chondrocytes via novel collagen-glycosaminoglycan matrices Hum. Gene Ther. 13 2002 791-802
25. Quick D.J. Anseth K.S. Gene delivery in tissue engineering: a photopolymer platform to coencapsulate cells and plasmid DNA Pharm. Res. 20 2003 1730-1737
26. Yun Y.H. Goetz D.J. Yellen P. Chen W. Hyaluronan microspheres for sustained gene delivery and site-specific targeting Biomaterials 25 2004 147-157
27. Niidome T. Huang L. Gene therapy progress and prospects: nonviral vectors Gene Ther. 9 2002 1647-1652
28. Nishikawa M. Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer Hum. Gene Ther. 12 2001 861-870
29. Herweijer H. Wolff J.A. Progress and prospects: naked DNA gene transfer and therapy Gene Ther. 10 2003 453-458
30. Ledley F.D. Pharmaceutical approach to somatic gene therapy Pharm. Res. 13 1996 1595-1614
31. Zaharoff D.A. Barr R.C. Li C.Y. Yuan F. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery Gene Ther. 9 2002 1286-1290
32. De Rosa G. Quaglia F. La Rotonda M.I. Appel M. Alphandary H. Fattal E. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes J. Pharm. Sci. 91 2002 790-799
33. Kim A. Checkla D.M. Dehazya P. Chen W.L. Characterization of DNA-hyaluronan matrix for sustained gene transfer J. Controlled Release 90 2003 81-95
34. Eliaz R.E. Szoka F.C. Jr. Robust and prolonged gene expression from injectable polymeric implants Gene Ther. 9 2002 1230-1237
35. Nof M. Shea L.D. Drug-releasing scaffolds fabricated from drug-loaded microspheres J. Biomed. Mater. Res. 59 2002 349-356
36. Shen H. Goldberg E. Saltzman W.M. Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix J. Controlled Release 86 2003 339-348
37. Jong Y.S. et al. Controlled release of plasmid DNA J. Controlled Release 47 1997 123-134
38. Panyam J. Zhou W.Z. Prabha S. Sahoo S.K. Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery FASEB J. 16 2002 1217-1226
39. Sandor M. et al. Transfection of HEK cells via DNA-loaded PLGA and P(FASA) nanospheres J. Drug Targeting 10 2002 497-506
40. Cohen H. et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles Gene Ther. 7 2000 1896-1905
41. Leong K.W. Mao H.Q. Truong-Le V.L. Roy K. Walsh S.M. August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles J. Controlled Release 53 1998 183-193
42. Truong-Le V.L. et al. Gene transfer by DNA-gelatin nanospheres Arch. Biochem. Biophys. 361 1999 47-56
43. Aoyama T. Yamamoto S. Kanematsu A. Ogawa O. Tabata Y. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice Tissue Eng. 9 2003 1289-1299
44. Zheng J. Manuel W.S. Hornsby P.J. Transfection of cells mediated by biodegradable polymer materials with surface-bound polyethyleneimine Biotechnol. Prog. 16 2000 254-257
45. Cohen-Sacks H. et al. Delivery and expression of pDNA embedded in collagen matrices J. Controlled Release 95 2004 309-320
46. Denis-Mize K.S. et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells Gene Ther. 7 2000 2105-2112
47. Segura T. Shea L.D. Materials for non-viral gene delivery Annu. Rev. Mater. Sci. 31 2001 25-36
48. Varga C.M. Hong K. Lauffenburger D.A. Quantitative analysis of synthetic gene delivery vector design properties Mol. Ther. 4 2001 438-446
49. Capan Y. Woo B.H. Gebrekidan S. Ahmed S. DeLuca P.P. Stability of poly(l-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment Pharm. Dev. Technol. 4 1999 491-498
50. Capan Y. Woo B.H. Gebrekidan S. Ahmed S. DeLuca P.P. Influence of formulation parameters on the characteristics of poly(dl-lactide-co-glycolide) microspheres containing poly(l-lysine) complexed plasmid DNA J. Controlled Release 60 1999 279-286
51. Huang Y.C. Connell M. Park Y. Mooney D.J. Rice K.G. Fabrication and in vitro testing of polymeric delivery system for condensed DNA J. Biomed. Mater. Res. 67A 2003 1384-1392
52. Moret I. et al. Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum J. Controlled Release 76 2001 169-181
53. Zelphati O. Uyechi L.S. Barron L.G. Szoka F.C. Jr. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells Biochim. Biophys. Acta 1390 1998 119-133
54. De Rosa G. Quaglia F. La Rotonda M.I. Besnard M. Fattal E. Biodegradable microparticles for the controlled delivery of oligonucleotides Int. J. Pharm. 242 2002 225-228
55. Segura T. Volk M.J. Shea L.D. Substrate-mediated DNA delivery: role of the cationic polymer structure and extent of modification J. Controlled Release 93 2003 69-84
56. Bielinska A.U. et al. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo Biomaterials 21 2000 877-887
57. Kneuer C. et al. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro Bioconjugate Chem. 11 2000 926-932
58. Manuel W.S. Zheng J.I. Hornsby P.J. Transfection by polyethyleneimine-coated microspheres J. Drug Targeting 9 2001 15-22
59. Kofron M.D. Laurencin C.T. Development of a calcium phosphate co-precipitate/poly(lactide-co-glycolide) DNA delivery system: release kinetics and cellular transfection studies Biomaterials 25 2004 2637-2643
60. Anderson W.F. Human gene therapy Nature 392 1998 25-30
61. Alden T.D. et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector Hum. Gene Ther. 10 1999 2245-2253
62. Musgrave D.S. Bosch P. Ghivizzani S. Robbins P.D. Evans C.H. Huard J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone Bone 24 1999 541-547
63. Okubo Y. Bessho K. Fujimura K. Iizuka T. Miyatake S.I. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression Biochem. Biophys. Res. Commun. 267 2000 382-387
64. Beer S.J. Hilfinger J.M. Davidson B.L. Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors Adv. Drug Delivery Rev. 27 1997 59-66
65. Beer S.J. Matthews C.B. Stein C.S. Ross B.D. Hilfinger J.M. Davidson B.L. Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo Gene Ther. 5 1998 740-746
66. Sailaja G. HogenEsch H. North A. Hays J. Mittal S.K. Encapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response Gene Ther. 9 2002 1722-1729
67. Matthews C. Jenkins G. Hilfinger J. Davidson B. Poly-l-lysine improves gene transfer with adenovirus formulated in PLGA microspheres Gene Ther. 6 1999 1558-1564
68. Doukas J. et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors Hum. Gene Ther. 12 2001 783-798
69. Chandler L.A. et al. FGF2-targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation Mol. Ther. 2 2000 153-160
70. Gu D. Nguyen T. Phillips M.L. Chandler L.A. Sosnowski B.A. Matrix-immobilized growth factor gene therapy enhances tissue repair Wounds 16 2004 34-41
71. Kalyanasundaram S. Feinstein S. Nicholson J.P. Leong K.W. Garver R.I. Jr. Coacervate microspheres as carriers of recombinant adenoviruses Cancer Gene Ther. 6 1999 107-112
72. Cavanagh H.M. Dingwall D. Steel J. Benson J. Burton M. Cell contact dependent extended release of adenovirus by microparticles in vitro J. Virol. Methods 95 2001 57-64
73. Mah C. et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy Mol. Ther. 6 2002 106-112
74. Abrahams J.M. Song C. DeFelice S. Grady M.S. Diamond S.L. Levy R.J. Endovascular microcoil gene delivery using immobilized anti-adenovirus antibody for vector tethering Stroke 33 2002 1376-1382
75. Klugherz B.D. et al. Gene delivery to pig coronary arteries from stents carrying antibody-tethered adenovirus Hum. Gene Ther. 13 2002 443-454
76. Pandori M. Hobson D. Sano T. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery Virology 299 2002 204-212
77. Parrott M.B. Barry M.A. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice Mol. Ther. 1 2000 96-104
78. Parrott M.B. Barry M.A. Metabolic biotinylation of secreted and cell surface proteins from mammalian cells Biochem. Biophys. Res. Commun. 281 2001 993-1000
79. Lee J.H. et al. Engineering novel cell surface receptors for virus-mediated gene transfer J. Biol. Chem. 274 1999 21878-21884
80. Pagliaro L.C. et al. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy J. Clin. Oncol. 21 2003 2247-2253
81. Palmer D.H. Chen M.J. Kerr D.J. Taking gene therapy into the clinic J. Biomed. Biotechnol. 2003 2003 71-77
82. Kerr D. Clinical development of gene therapy for colorectal cancer Nat. Rev. Cancer. 3 2003 615-622
83. Rainovy N.G. Ren H. Gene therapy for human malignant brain tumors Cancer J. 9 2003 180-188
84. Powell J.S. et al. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion Blood 102 2003 2038-2045
85. Mohapatra S.S. Mucosal gene expression vaccine: a novel vaccine strategy for respiratory syncytial virus Pediatr. Infect. Dis. J. 22 2003 S100 S103 discussion S103-S104
86. Siemens D.R. Austin J.C. Hedican S.P. Tartaglia J. Ratliff T.L. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model J. Natl. Cancer Inst. 92 2000 403-412
87. Murphy W.L. Mooney D.J. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices J. Periodont. Res. 34 1999 413-419
88. Fang J. et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes Proc. Natl. Acad. Sci. USA 93 1996 5753-5758
89. Labhasetwar V. Bonadio J. Goldstein S.A. Levy J.R. Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model Colloids Surf. B 16 1999 281-290
90. Pascher A. et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate Gene Ther. 11 2004 133-141
91. Berry M. et al. Sustained effects of gene-activated matrices after CNS injury Mol. Cell. Neurosci. 17 2001 706-716
92. Tyrone J.W. et al. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model J. Surg. Res. 93 2000 230-236
93. Doukas J. et al. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle Mol. Ther. 5 2002 517-527
94. Klugherz B.D. et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries Nat. Biotechnol. 18 2000 1181-1184
95. Stachelek S.J. et al. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants Gene Ther. 11 2004 15-24
96. Saltzman W.M. Olbricht W.L. Building drug delivery into tissue engineering Nat. Rev. Drug Discovery 1 2002 177-186
97. Ziauddin J. Sabatini D.M. Microarrays of cells expressing defined cDNAs Nature 411 2001 107-110
98. Michiels F. et al. Arrayed adenoviral expression libraries for functional screening Nat. Biotechnol. 20 2002 1154-1157
99. Honma K. et al. Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions Biochem. Biophys. Res. Commun. 289 2001 1075-1081
100. Wu R.Z. Bailey S.N. Sabatini D.M. Cell-biological applications of transfected-cell microarrays Trends Cell Biol. 12 2002 485-488
101. Kasahara H. et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia J. Am. Coll. Cardiol. 41 2003 1056-1062